This is a preview of subscription content, log in via an institution to check access.
Reference
Raj SM, et al. Cost-benefit analysis of a national influenza vaccination program in preventing hospitalisation costs in Australian adults aged 50-64 years old. Vaccine : 28 Aug 2019. Available from: URL: http://doi.org/10.1016/j.vaccine.2019.08.028
Rights and permissions
About this article
Cite this article
Influenza vaccination for age 50−64 cost beneficial in Australia. PharmacoEcon Outcomes News 836, 15 (2019). https://doi.org/10.1007/s40274-019-6188-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-6188-8